Profilo
Sharon Barr has held the following positions in her career: EVP-BioPharmaceuticals Research & Development at AstraZeneca PLC starting in 2023, and Senior VP, Head-Research & Product Development at Alexion Pharmaceuticals, Inc.
Posizioni attive di Sharon Barr
| Società | Posizione | Inizio |
|---|---|---|
| ASTRAZENECA PLC | Direttore Tecnico/Scientifico/R&S | 01/08/2023 |
| ALEXION PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Borsa valori
- Insiders
- Sharon Barr
